Praxis Precision Medicines’ $264 Milion Collaboration and License Agreement with Tenacia Biotechnology

Leila Ahmed
Tagged:

Sidley Austin represented Praxis Precision Medicines, Inc. in the transaction, and Ropes & Gray advised Tenacia.Praxis Precision Medicines, Inc. (NASDAQ: PRAX) announced it has entered into…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now